Reimagine Vitiligo Treatment with Lumirix®
Lumirix® is the first topical treatment approved for vitiligo.
Learn more
Why Choose Lumirix® for Your Vitiligo Treatment?

1.
Clinically Proven Results
Lumirix® is supported by clinical studies that show significant improvements in skin repigmentation.²
2.
Treatment Approach
Lumirix® works by targeting the underlying mechanisms of vitiligo, providing a focused treatment approach.
3.
Proven Safety Profile
Lumirix® has demonstrated a favorable safety profile in clinical trials with manageable side effects.
4.
Comprehensive Support
Get comprehensive patient support and resources to help you throughout your treatment journey.
References:
- Grossmann MC, Haidari W, Feldman SR. A Review on the Use of Topical Ruxolitinib for the Treatment of Vitiligo. Journal of drugs in dermatology: JDD. 2023;22
- Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D. Two phase 3, randomized, controlled trials of Ruxolitinib cream for vitiligo. New England Journal of Medicine. 2022 Oct 20;387(16):1445-55.
- Lumirix Prescribing information for Hong Kong.